TAK Stock Summary and Trading Ideas (Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) | NYSE:TAK)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) trades on the NYSE stock market under the symbol TAK.

As of April 23, 2024, TAK stock price climbed to $13.38 with 1,691,745 million shares trading.

TAK has a beta of 0.47, meaning it tends to be less sensitive to market movements. TAK has a correlation of 0.12 to the broad based SPY ETF.

TAK has a market cap of $41.98 billion. This is considered a Large Cap stock.

In the last 3 years, TAK stock traded as high as $17.56 and as low as $12.28.

The top ETF exchange traded funds that TAK belongs to (by Net Assets): PPH, APIE, AVDE, VEU, PTIN.

TAK has underperformed the market in the last year with a return of -20.6%, while the SPY ETF gained +24.3%. In the last 3 month period, TAK fell short of the market, returning -9.5%, while SPY returned +4.9%. However, in the most recent 2 weeks TAK has outperformed the stock market by returning -2.1%, while SPY returned -2.5%.

TAK support price is $13.22 and resistance is $13.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAK stock will trade within this expected range on the day.